EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Rethinking Vitamin D Deficiency: Controversies and Practical Guidance for Clinical Management

Manuel Sosa-Henríquez iD, Óscar Torregrosa-Suau iD, María Jesús Gómez de Tejada-Romero iD, María Jesús Cancelo-Hidalgo iD, Francisco José Tarazona-Santabalbina iD, Iñigo Etxebarria-Foronda iD, Guillermo Martínez Díaz-Guerra iD, Carmen Valdés-Llorca iD

Nutrients · 15.11.2025 · 17 (22) · 3573

DOI: 10.3390/nu17223573 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 15.11.2025. Verfasst von Manuel Sosa-Henríquez und 7 weiteren Autor:innen. Beteiligte Einrichtung: D-Evidence Working Group, Spanish Working Group on Vitamin D. Hauptthemen laut MEDLINE: Vitamin D Deficiency, Vitamin D. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitamin D (VD), due to its hormonal action, plays a crucial role in calcium homeostasis and bone metabolism, and its deficiency has been associated with musculoskeletal disorders such as osteoporosis, fractures, and osteomalacia, as well as a growing attention of chronic conditions and certain cancers. Despite its physiological relevance and widespread prevalence, particularly among older individuals, patients with chronic diseases, institutionalized populations and pregnant or lactating women, clinical approaches to diagnosing and managing vitamin D deficiency (VDD) remain heterogeneous across guidelines and healthcare settings. This reflects a lack of consensus regarding the benefits and limitations of universal versus selective screening, the definition of adequate serum concentrations, and the clinical indications for supplementation across different patient profiles. This narrative review explores key controversies in the clinical management of VDD, including current perspectives on screening strategies and target populations, indications for empirical supplementation, criteria for biochemical monitoring, and therapeutic goals in bone-related outcomes. In particular, the review discusses the rationale for adopting a 30 ng/mL (75 nmol/L) threshold for adequate serum 25(OH) concentrations in skeletal health, the role of vitamin D and calcium in osteoporosis treatment, and the pharmacological advantages of cholecalciferol compared to other vitamin D compounds. Through a synthesis of available evidence and expert consensus, the review aims to support clinical decision-making in the prevention and treatment of VDD and to identify areas that require further clarification or research. This review aims to support evidence-based clinical decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin D DeficiencyVitamin DHumansDietary SupplementsOsteoporosisFemalePractice Guidelines as TopicCalcium

Stichwörter der Autor:innen

Vitamin Dcalcium homeostasisclinical screeningdeficiencysupplementation

Substanzen

Vitamin DCalcium

Autor:innen und Institutionen

  • D-Evidence Working Group, Spanish Working Group on Vitamin D.
  • Working Group on Osteoporosis and Bone Metabolic Diseases, Department of Medical and Surgical Sciences, University of Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain.
  • Bone Metabolic Unit, Service of Internal Medicine, Hospital General y Universitario de Elche, 03203 Alicante, Spain.
  • Department of Medicine, University of Seville, 41009 Seville, Spain.
  • University Hospital of Guadalajara, Alcalá University, 28801 Madrid, Spain.
  • Geriatric Service, Hospital University of La Ribera, 46600 Alzira, Spain.

ORCID-Profile: Manuel Sosa-Henríquez, Óscar Torregrosa-Suau, María Jesús Gómez de Tejada-Romero, María Jesús Cancelo-Hidalgo, Francisco José Tarazona-Santabalbina, Iñigo Etxebarria-Foronda, Guillermo Martínez Díaz-Guerra, Carmen Valdés-Llorca

Zitieren

APA

Sosa-Henríquez, M., Torregrosa-Suau, Ó., Gómez de Tejada-Romero, M. J., Cancelo-Hidalgo, M. J., Tarazona-Santabalbina, F. J., Etxebarria-Foronda, I., Díaz-Guerra, G. M., & Valdés-Llorca, C. (2025). Rethinking Vitamin D Deficiency: Controversies and Practical Guidance for Clinical Management. Nutrients, 17(22), 3573. https://doi.org/10.3390/nu17223573

Vancouver

Sosa-Henríquez M, Torregrosa-Suau Ó, Gómez de Tejada-Romero MJ, Cancelo-Hidalgo MJ, Tarazona-Santabalbina FJ, Etxebarria-Foronda I, et al. Rethinking Vitamin D Deficiency: Controversies and Practical Guidance for Clinical Management. Nutrients. 2025;17(22):3573. doi:10.3390/nu17223573

BibTeX
@article{SosaHenrquez2025,
  author = {Sosa-Henríquez, Manuel and Torregrosa-Suau, Óscar and Gómez de Tejada-Romero, María Jesús and Cancelo-Hidalgo, María Jesús and Tarazona-Santabalbina, Francisco José and Etxebarria-Foronda, Iñigo and Díaz-Guerra, Guillermo Martínez and Valdés-Llorca, Carmen},
  title = {Rethinking Vitamin D Deficiency: Controversies and Practical Guidance for Clinical Management},
  journal = {Nutrients},
  year = {2025},
  volume = {17},
  number = {22},
  pages = {3573},
  doi = {10.3390/nu17223573}
}
Kostenlos starten →